Abstract
A novel series of isatin-based inhibitors of β-secretase (BACE-1) have been identified using a virtual high-throughput screening approach. Structure-activity relationship studies revealed structural features important for inhibition. Docking studies suggest these inhibitors may bind within the BACE-1 active site through H-bonding interactions involving the catalytic aspartate residues. © 2009 Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 6770-6774 |
Number of pages | 4 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 19 |
Issue number | 23 |
DOIs | |
Publication status | Published - 1 Dec 2009 |
Keywords
- β-Secretase
- Alzheimer's disease
- BACE-1
- eHiTS
- Virtual high-throughput screening
Research Beacons, Institutes and Platforms
- Dementia@Manchester